CMRX - Chimerix Inc
IEX Last Trade
0.947
0.006 0.634%
Share volume: 123,402
Last Updated: Fri 30 Aug 2024 09:56:29 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.94
0.01
0.64%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-08 | 2022-11-03 | 2023-03-02 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-29 | 2024-05-01 | |
Total revenue | 440.000 K | 32.555 M | 814.000 K | 283.000 K | 26.000 K | 11.000 K | 4.000 K | 0.000 | |
Cost of revenue | 0.000 | 333.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 440.000 K | 32.222 M | 814.000 K | 283.000 K | 26.000 K | 11.000 K | 4.000 K | 0.000 | |
7,223.18% | -97.47% | -65.23% | -90.81% | -57.69% | -63.64% | -100.00% | |||
Operating expenses | 23.887 M | 20.576 M | 24.628 M | 24.501 M | 21.374 M | 26.700 M | 20.814 M | 24.390 M | |
Selling general and admin | 5.840 M | 5.313 M | 5.347 M | 5.679 M | 4.448 M | 9.304 M | 5.170 M | 5.546 M | |
Research and development | 18.047 M | 15.263 M | 19.281 M | 18.822 M | 16.926 M | 17.396 M | 15.644 M | 18.844 M | |
Total expenses | 23.887 M | 20.909 M | 24.628 M | 24.501 M | 21.374 M | 26.700 M | 20.814 M | 24.390 M | |
-12.47% | 17.79% | -0.52% | -12.76% | 24.92% | -22.04% | 17.18% | |||
Operating income | -23.447 M | 11.646 M | -23.814 M | -24.218 M | -21.348 M | -26.689 M | -20.810 M | -24.390 M | |
Ebit | -23.447 M | 11.646 M | -23.814 M | -24.218 M | -21.348 M | -26.689 M | -20.810 M | -24.390 M | |
Pretax income | -23.468 M | 241.515 M | -21.077 M | -21.372 M | -18.576 M | -23.986 M | -18.161 M | -21.869 M | |
-1,129.12% | -108.73% | 1.40% | -13.08% | 29.12% | -24.28% | 20.42% | |||
Income tax | 0.000 | 153.000 K | -117.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -23.468 M | 241.362 M | -20.960 M | -21.372 M | -18.576 M | -23.986 M | -18.161 M | -21.869 M | |
1,128.47% | -108.68% | -1.97% | 13.08% | -29.12% | 24.28% | -20.42% | |||
Net income | -23.468 M | 241.362 M | -20.960 M | -21.372 M | -18.576 M | -23.986 M | -18.161 M | -21.869 M | |
1,128.47% | -108.68% | -1.97% | 13.08% | -29.12% | 24.28% | -20.42% |